Dr. Laura Minto, MD

NPI: 1386791259
Total Payments
$83,902
2024 Payments
$3,365
Companies
48
Transactions
693
Medicare Patients
621
Medicare Billing
$74,123

Payment Breakdown by Category

Other$50,406 (60.1%)
Food & Beverage$12,349 (14.7%)
Travel$11,555 (13.8%)
Consulting$9,450 (11.3%)
Education$141.49 (0.2%)

Payments by Nature

Nature of Payment Amount Transactions Share
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $50,406 22 60.1%
Food and Beverage $12,349 643 14.7%
Travel and Lodging $11,555 18 13.8%
Consulting Fee $9,450 2 11.3%
Education $141.49 8 0.2%

Top Paying Companies

Company Total Records Latest Year
Biogen, Inc. $35,405 58 $0 (2024)
Genentech USA, Inc. $31,150 68 $0 (2024)
Novartis Pharmaceuticals Corporation $9,311 125 $0 (2024)
ABBVIE INC. $1,514 106 $0 (2024)
EMD Serono, Inc. $951.12 39 $0 (2024)
Lilly USA, LLC $438.15 24 $0 (2024)
PFIZER INC. $437.87 30 $0 (2024)
Lundbeck LLC $416.45 23 $0 (2024)
Eisai Inc. $371.06 21 $0 (2024)
ARGENX US, INC. $338.68 12 $0 (2024)

Payment History by Year

Year Amount Transactions Top Company
2024 $3,365 170 EMD Serono, Inc. ($655.92)
2023 $2,605 151 ABBVIE INC. ($464.20)
2022 $1,676 95 ABBVIE INC. ($402.18)
2021 $331.48 19 SK Life Science, Inc. ($86.36)
2020 $258.14 17 Sunovion Pharmaceuticals Inc. ($108.61)
2019 $14,050 45 Genentech USA, Inc. ($13,388)
2018 $25,650 97 Genentech USA, Inc. ($10,506)
2017 $35,967 99 Biogen, Inc. ($28,358)

All Payment Transactions

693 individual payment records from CMS Open Payments — Page 1 of 28

Date Company Product Nature Form Amount Type
12/19/2024 ACADIA Pharmaceuticals Inc NUPLAZID (Drug) Food and Beverage In-kind items and services $24.10 General
Category: PARKINSONS DISEASE PSYCHOSIS
12/17/2024 PFIZER INC. NURTEC ODT (Drug), ZAVZPRET Food and Beverage In-kind items and services $13.15 General
Category: PAIN
12/17/2024 PFIZER INC. NURTEC ODT (Drug), ZAVZPRET Food and Beverage In-kind items and services $3.07 General
Category: PAIN
12/16/2024 Genentech USA, Inc. Ocrevus (Biological), Ocrevus Zunovo Food and Beverage In-kind items and services $18.94 General
Category: Immunology
12/12/2024 EMD Serono, Inc. Food and Beverage Cash or cash equivalent $13.86 General
12/11/2024 Lundbeck LLC VYEPTI (Biological) Food and Beverage Cash or cash equivalent $16.67 General
Category: NEUROLOGY
12/10/2024 EMD Serono, Inc. Travel and Lodging Cash or cash equivalent $202.31 General
12/10/2024 EMD Serono, Inc. Food and Beverage Cash or cash equivalent $90.00 General
12/10/2024 Lilly USA, LLC EMGALITY (Drug) Food and Beverage In-kind items and services $22.44 General
Category: Neuroscience
12/09/2024 Novartis Pharmaceuticals Corporation KESIMPTA (Drug) Food and Beverage In-kind items and services $25.86 General
Category: Neurology
12/07/2024 EMD Serono, Inc. Food and Beverage Cash or cash equivalent $75.00 General
12/07/2024 EMD Serono, Inc. Food and Beverage Cash or cash equivalent $35.00 General
12/07/2024 EMD Serono, Inc. Food and Beverage Cash or cash equivalent $35.00 General
12/06/2024 EMD Serono, Inc. Food and Beverage Cash or cash equivalent $33.94 General
12/03/2024 EMD Serono, Inc. Food and Beverage Cash or cash equivalent $27.68 General
12/03/2024 ABBVIE INC. VYALEV (Drug) Food and Beverage In-kind items and services $15.16 General
Category: NEUROSCIENCE
12/02/2024 SK Life Science, Inc. Food and Beverage In-kind items and services $23.00 General
11/27/2024 ABBVIE INC. BOTOX (Biological) Food and Beverage In-kind items and services $15.64 General
Category: BOTOX THERAPEUTIC
11/27/2024 ABBVIE INC. BOTOX (Biological) Food and Beverage In-kind items and services $2.04 General
Category: BOTOX THERAPEUTIC
11/26/2024 Eisai Inc. Leqembi (Drug) Food and Beverage In-kind items and services $5.90 General
Category: Neurology
11/21/2024 PFIZER INC. NURTEC ODT (Drug), ZAVZPRET Food and Beverage In-kind items and services $16.97 General
Category: PAIN
11/21/2024 EMD Serono, Inc. Food and Beverage Cash or cash equivalent $11.13 General
11/21/2024 ABBVIE INC. UBRELVY (Drug), QULIPTA Food and Beverage In-kind items and services $4.21 General
Category: NEUROSCIENCE
11/21/2024 PFIZER INC. NURTEC ODT (Drug), ZAVZPRET Food and Beverage In-kind items and services $2.74 General
Category: PAIN
11/19/2024 ABBVIE INC. BOTOX (Biological), QULIPTA Food and Beverage In-kind items and services $28.78 General
Category: BOTOX THERAPEUTIC

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 6 369 468 $84,488 $45,154
2022 5 171 188 $37,795 $19,295
2021 1 36 57 $14,649 $4,797
2020 2 45 63 $17,894 $4,876
Total Patients
621
Total Services
776
Medicare Billing
$74,123
Procedure Codes
14

All Medicare Procedures & Services

14 procedure records from CMS Medicare Utilization

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 151 246 $37,884 $21,388 56.5%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2023 116 116 $26,680 $13,396 50.2%
99205 New patient office or other outpatient visit, 60-74 minutes Office 2023 28 28 $8,390 $4,148 49.4%
99222 Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes Facility 2023 39 39 $7,410 $3,865 52.2%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 21 22 $2,424 $1,332 55.0%
99232 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes Facility 2023 14 17 $1,700 $1,025 60.3%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 69 84 $15,308 $7,481 48.9%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2022 56 56 $13,038 $6,819 52.3%
99222 Initial hospital inpatient care per day, typically 50 minutes Facility 2022 22 22 $4,180 $2,246 53.7%
99205 New patient office or other outpatient visit, 60-74 minutes Office 2022 13 13 $3,969 $2,044 51.5%
99232 Follow-up hospital inpatient care per day, typically 25 minutes Facility 2022 11 13 $1,300 $705.25 54.3%
99214 Established patient outpatient visit, total time 30-39 minutes Office 2021 36 57 $14,649 $4,797 32.7%
99214 Established patient office or other outpatient, visit typically 25 minutes Office 2020 33 51 $13,238 $3,681 27.8%
99204 New patient office or other outpatient visit, typically 45 minutes Office 2020 12 12 $4,656 $1,195 25.7%

About Dr. Laura Minto, MD

Dr. Laura Minto, MD is a Neurology healthcare provider based in Mobile, Alabama. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/04/2007. The National Provider Identifier (NPI) number assigned to this provider is 1386791259.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Laura Minto, MD has received a total of $83,902 in payments from pharmaceutical and medical device companies, with $3,365 received in 2024. These payments were reported across 693 transactions from 48 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($50,406).

As a Medicare-enrolled provider, Minto has provided services to 621 Medicare beneficiaries, totaling 776 services with total Medicare billing of $74,123. Data is available for 4 years (2020–2023), covering 14 distinct procedure/service records.

Practice Information

  • Specialty Neurology
  • Location Mobile, AL
  • Active Since 01/04/2007
  • Last Updated 02/22/2017
  • Taxonomy Code 2084N0400X
  • Entity Type Individual
  • NPI Number 1386791259

Products in Payments

  • OCREVUS (Biological) $24,133
  • TECFIDERA (Drug) $20,006
  • GILENYA (Drug) $8,226
  • Non-Covered Product (Drug) $6,604
  • ZINBRYTA (Biological) $6,007
  • TYSABRI (Biological) $5,932
  • KESIMPTA (Drug) $686.98
  • QULIPTA (Drug) $625.58
  • BOTOX (Biological) $589.92
  • NURTEC ODT (Drug) $452.73
  • Ocrevus (Biological) $407.16
  • ZEPOSIA (Drug) $340.24
  • APTIOM (Drug) $320.65
  • Leqembi (Drug) $305.75
  • UBRELVY (Drug) $304.13
  • VYVGART (Drug) $293.47
  • NUPLAZID (Drug) $290.22
  • VYEPTI (Biological) $288.74
  • AMYVID (Drug) $279.88
  • LEMTRADA (Drug) $212.32

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Neurology Doctors in Mobile